Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K, filed on November 2, 2021, reports the third-quarter results for the period ending September 30, 2021. The filing serves to distribute a press release (Exhibit 99.1) and a complete overview of financial figures for the third quarter and the first nine months of 2021 (Exhibit 99.2).
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibits 99.1 and 99.2. The Company utilizes the following non-GAAP measures to supplement IFRS reporting:
- EBITDA (Operating income excluding interest, taxes, depreciation, and amortization)
- Adjusted EBITDA
- Free Cash Flow
- Net Leverage Ratio (Net debt to adjusted EBITDA)
- Results presented in constant currency
Reconciliations between these non-GAAP measures and the most comparable IFRS measures are included in the attached financial statements.
Material Changes and Comparisons
The filing text does not explicitly state material changes versus the prior comparable period. It notes that the attached press release contains results for the third quarter and the first nine months of 2021, which should be reviewed for period-over-period comparisons.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, or risk factors. It states that the non-GAAP measures are provided to enhance the understanding of current performance and future prospects. The Company emphasizes that these non-GAAP measures should not be used as a substitute for GAAP financial measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, EBITDA, and free cash flow figures for Q3 and YTD 2021.
- Examine Exhibit 99.2 for the complete financial overview and reconciliation of non-GAAP to IFRS measures.
- Verify the Net Leverage Ratio and debt levels in the attached financial statements.
- Check the press release for any updated full-year guidance or commentary on the impact of the pandemic and currency fluctuations.